Replimune Group's Q3 2024 Financial Highlights

TipRanksNov 14 12:12

BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14

Futu NewsNov 13 20:31 · Ratings

Barclays Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17

Futu NewsNov 13 18:38 · Ratings

Replimune Group Navigates Clinical, Regulatory, and Market Challenges Amid Global Uncertainties

TipRanksNov 13 14:00

H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17

Futu NewsNov 13 00:32 · Ratings

HC Wainwright & Co. Reiterates Buy on Replimune Group, Maintains $17 Price Target

BenzingaNov 13 00:23 · Ratings